Challenges to Building a Gene Variant Commons to Assess Hereditary Cancer Risk: Results of a Modified Policy Delphi Panel Deliberation
Understanding the clinical significance of variants associated with hereditary cancer risk requires access to a pooled data resource or network of resources—a “cancer gene variant commons”—incorporating representative, well-characterized genetic data, metadata, and, for some purposes, pathways to ca...
Main Authors: | Mary A. Majumder, Matthew L. Blank, Janis Geary, Juli M. Bollinger, Christi J. Guerrini, Jill Oliver Robinson, Isabel Canfield, Robert Cook-Deegan, Amy L. McGuire |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/7/646 |
Similar Items
-
Leveraging unstructured data to identify hereditary angioedema patients in electronic medical records
by: Emily S. Brouwer, et al.
Published: (2021-04-01) -
Integrating Technical and Legal Concepts of Privacy
by: Ana Sokolovska, et al.
Published: (2018-01-01) -
Hereditary Colorectal Cancer (CRC) Program in Latvia
by: Irmejs Arvids, et al.
Published: (2003-12-01) -
Practical Data-in-Use Protection Using Binary Decision Diagrams
by: Oleg Mazonka, et al.
Published: (2020-01-01) -
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
by: M. Digennaro, et al.
Published: (2017-05-01)